MainOffice of Compliance (OC) staff are in great demand to present information on latest guidances, inspectional findings, and current enforcement strategies at industry conferences. OC carefully balances the value of the multiplier effect of outreach activity with other aspects of our work. <br>This measure has been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research. </b> Number

Oct 200920Nov 200911Dec 20095Jan 20104Feb 20106Mar 201013Apr 201019May 201022Jun 201019Jul 20102Aug 20104Sep 201011

Oct 201014Nov 20109Dec 20101Jan 201110Feb 20119Mar 201113Apr 201114May 201124Jun 201129Jul 20114Aug 20118Sep 201136http://www.fda.gov/AboutFDA/Transparency/track/ucm206444.htmFDA-TRACK CDER Dashboard